Aeterna Zentaris Inc.

TSX:AEZS Stock Report

Market Cap: CA$12.9m

Aeterna Zentaris Management

Management criteria checks 2/4

Aeterna Zentaris' CEO is Klaus Paulini, appointed in Oct 2019, has a tenure of 4.5 years. total yearly compensation is $964.55K, comprised of 33.6% salary and 66.4% bonuses, including company stock and options. directly owns 0.086% of the company’s shares, worth CA$11.17K. The average tenure of the management team and the board of directors is 3.7 years and 4.4 years respectively.

Key information

Klaus Paulini

Chief executive officer

US$964.5k

Total compensation

CEO salary percentage33.6%
CEO tenure4.5yrs
CEO ownership0.09%
Management average tenure3.7yrs
Board average tenure4.4yrs

Recent management updates

Recent updates

We're Hopeful That Aeterna Zentaris (TSE:AEZS) Will Use Its Cash Wisely

May 10
We're Hopeful That Aeterna Zentaris (TSE:AEZS) Will Use Its Cash Wisely

We're Interested To See How Aeterna Zentaris (TSE:AEZS) Uses Its Cash Hoard To Grow

Nov 12
We're Interested To See How Aeterna Zentaris (TSE:AEZS) Uses Its Cash Hoard To Grow

Here's Why We're Not At All Concerned With Aeterna Zentaris' (TSE:AEZS) Cash Burn Situation

Jul 15
Here's Why We're Not At All Concerned With Aeterna Zentaris' (TSE:AEZS) Cash Burn Situation

Companies Like Aeterna Zentaris (TSE:AEZS) Can Afford To Invest In Growth

Mar 29
Companies Like Aeterna Zentaris (TSE:AEZS) Can Afford To Invest In Growth

Reflecting on Aeterna Zentaris' (TSE:AEZS) Share Price Returns Over The Last Five Years

Feb 04
Reflecting on Aeterna Zentaris' (TSE:AEZS) Share Price Returns Over The Last Five Years

CEO Compensation Analysis

How has Klaus Paulini's remuneration changed compared to Aeterna Zentaris's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$965kUS$324k

-US$17m

Sep 30 2023n/an/a

-US$23m

Jun 30 2023n/an/a

-US$23m

Mar 31 2023n/an/a

-US$24m

Dec 31 2022US$584kUS$320k

-US$23m

Sep 30 2022n/an/a

-US$13m

Jun 30 2022n/an/a

-US$12m

Mar 31 2022n/an/a

-US$10m

Dec 31 2021US$786kUS$374k

-US$8m

Sep 30 2021n/an/a

-US$7m

Jun 30 2021n/an/a

-US$6m

Mar 31 2021n/an/a

-US$7m

Dec 31 2020US$792kUS$306k

-US$5m

Sep 30 2020n/an/a

-US$5m

Jun 30 2020n/an/a

-US$4m

Mar 31 2020n/an/a

-US$352k

Dec 31 2019US$478kUS$197k

-US$6m

Sep 30 2019n/an/a

-US$10m

Jun 30 2019n/an/a

-US$12m

Mar 31 2019n/an/a

-US$15m

Dec 31 2018US$189kUS$164k

US$4m

Sep 30 2018n/an/a

US$9m

Jun 30 2018n/an/a

US$2m

Mar 31 2018n/an/a

US$2m

Dec 31 2017US$133kUS$130k

-US$17m

Compensation vs Market: Klaus's total compensation ($USD964.55K) is above average for companies of similar size in the Canadian market ($USD175.48K).

Compensation vs Earnings: Klaus's compensation has increased whilst the company is unprofitable.

CEO

Klaus Paulini

4.5yrs

Tenure

US$964,545

Compensation

Dr. Klaus Paulini, Ph D., has been President, Chief Executive Officer and Executive Director at Aeterna Zentaris Inc., since October 4, 2019. Dr. Paulini has been Managing Director at Aeterna Zentaris GmbH...

Leadership Team

NamePositionTenureCompensationOwnership
Klaus Paulini
President4.5yrsUS$964.55k0.086%
$ 11.2k
Giuliano La Fratta
Senior VP of Finance & CFO2.3yrsUS$254.19kno data
Michael Teifel
Senior VP of Non-Clinical Development & Chief Scientific Officer2.9yrsUS$248.24kno data
Nicola Ammer
Chief Medical Officer & Senior VP of Clinical Development6.3yrsUS$212.55kno data
Matthias Gerlach
Senior Vice President Manufacturing & Supply Chainno dataUS$263.11kno data

3.7yrs

Average Tenure

Experienced Management: AEZS's management team is considered experienced (3.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Klaus Paulini
President4.5yrsUS$964.55k0.086%
$ 11.2k
Dennis Turpin
Independent Director2.9yrsUS$229.00k0.026%
$ 3.4k
Gilles Gagnon
Independent Director4.3yrsUS$133.50kno data
Gerald Batist
Member of the Scientific Advisory Boardno datano datano data
Hartmut Michel
Member of the Scientific Advisory Boardno datano datano data
Marcel Verheij
Member of the Scientific Advisory Boardno datano datano data
René Frydman
Member of the Scientific Advisory Boardno datano datano data
Alan DeCherney
Member of the Scientific Advisory Boardno datano datano data
Klaus Diedrich
Member of the Scientific Advisory Boardno datano datano data
Frans Debruyne
Member of the Scientific Advisory Boardno datano datano data
Ulf Rapp
Member of the Scientific Advisory Boardno datano datano data
Carolyn Egbert
Independent Chair of the Board11.7yrsUS$244.00k0.039%
$ 5.0k

4.4yrs

Average Tenure

Experienced Board: AEZS's board of directors are considered experienced (4.4 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.